BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 32812471)

  • 1. Cardiac Conduction Disorders as Markers of Cardiac Events in Myotonic Dystrophy Type 1.
    Itoh H; Hisamatsu T; Tamura T; Segawa K; Takahashi T; Takada H; Kuru S; Wada C; Suzuki M; Suwazono S; Sasaki S; Okumura K; Horie M; Takahashi MP; Matumura T
    J Am Heart Assoc; 2020 Sep; 9(17):e015709. PubMed ID: 32812471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of clinical and electrocardiographic data for predicting adverse cardiac events in patients with myotonic dystrophy.
    Breton R; Mathieu J
    Can J Cardiol; 2009 Feb; 25(2):e23-7. PubMed ID: 19214296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does cytosine-thymine-guanine (CTG) expansion size predict cardiac events and electrocardiographic progression in myotonic dystrophy?
    Clarke NR; Kelion AD; Nixon J; Hilton-Jones D; Forfar JC
    Heart; 2001 Oct; 86(4):411-6. PubMed ID: 11559681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of atrio-ventricular conduction disease, long-term outcomes in patients with myotonic dystrophy types I and II.
    Ha AH; Tarnopolsky MA; Bergstra TG; Nair GM; Al-Qubbany A; Healey JS
    Pacing Clin Electrophysiol; 2012 Oct; 35(10):1262-9. PubMed ID: 22385162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of mexiletine effect on conduction delay and bradyarrhythmic complications in patients with myotonic dystrophy type 1 over long-term follow-up.
    Vio R; Zorzi A; Bello L; Bozzoni V; Botta A; Rivezzi F; Leoni L; Migliore F; Bertaglia E; Iliceto S; Pegoraro E; Corrado D; Calore C
    Heart Rhythm; 2020 Nov; 17(11):1944-1950. PubMed ID: 32525073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrocardiographic abnormalities and sudden death in myotonic dystrophy type 1.
    Groh WJ; Groh MR; Saha C; Kincaid JC; Simmons Z; Ciafaloni E; Pourmand R; Otten RF; Bhakta D; Nair GV; Marashdeh MM; Zipes DP; Pascuzzi RM
    N Engl J Med; 2008 Jun; 358(25):2688-97. PubMed ID: 18565861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and predictors of sudden death, major conduction defects and sustained ventricular tachyarrhythmias in 1388 patients with myotonic dystrophy type 1.
    Wahbi K; Babuty D; Probst V; Wissocque L; Labombarda F; Porcher R; Bécane HM; Lazarus A; Béhin A; Laforêt P; Stojkovic T; Clementy N; Dussauge AP; Gourraud JB; Pereon Y; Lacour A; Chapon F; Milliez P; Klug D; Eymard B; Duboc D
    Eur Heart J; 2017 Mar; 38(10):751-758. PubMed ID: 27941019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association Between Mutation Size and Cardiac Involvement in Myotonic Dystrophy Type 1: An Analysis of the DM1-Heart Registry.
    Chong-Nguyen C; Wahbi K; Algalarrondo V; Bécane HM; Radvanyi-Hoffman H; Arnaud P; Furling D; Lazarus A; Bassez G; Béhin A; Fayssoil A; Laforêt P; Stojkovic T; Eymard B; Duboc D
    Circ Cardiovasc Genet; 2017 Jun; 10(3):. PubMed ID: 28611030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrophysiological study with prophylactic pacing and survival in adults with myotonic dystrophy and conduction system disease.
    Wahbi K; Meune C; Porcher R; Bécane HM; Lazarus A; Laforêt P; Stojkovic T; Béhin A; Radvanyi-Hoffmann H; Eymard B; Duboc D
    JAMA; 2012 Mar; 307(12):1292-301. PubMed ID: 22453570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Twenty-four-hour ambulatory ECG monitoring relevancy in myotonic dystrophy type 1 follow-up: Prognostic value and heart rate variability evolution.
    Gamet A; Degand B; Le Gal F; Bidegain N; Delaubier A; Gilbert-Dussardier B; Christiaens L; Garcia R
    Ann Noninvasive Electrocardiol; 2019 Jan; 24(1):e12587. PubMed ID: 30101452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular manifestations of myotonic dystrophy.
    Wahbi K; Furling D
    Trends Cardiovasc Med; 2020 May; 30(4):232-238. PubMed ID: 31213350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Normal Electrocardiogram Does Not Exclude Infra-Hisian Conduction Disease in Patients With Myotonic Dystrophy Type 1.
    Creta A; Providência R; Gossios T; Elliott PM; Turner C; Savvatis K; Segal OR
    JACC Clin Electrophysiol; 2021 Aug; 7(8):1038-1048. PubMed ID: 33812832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiologic predictors of sudden death in patients with myotonic dystrophy type 1.
    Rakocevic Stojanovic V; Peric S; Paunic T; Pavlovic S; Cvitan E; Basta I; Peric M; Milicev M; Lavrnic D
    J Clin Neurosci; 2013 Jul; 20(7):1002-6. PubMed ID: 23683744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [When do you implant a pacemaker in myotonic dystrophy?].
    Babuty D; Lallemand B; Laurent V; Clémenty N; Pierre B; Fauchier L; Raynaud M; Pellieux S
    Presse Med; 2011; 40(7-8):748-53. PubMed ID: 21549556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac manifestations in myotonic dystrophy type 1 patients followed using a standard protocol in a specialized unit.
    Facenda-Lorenzo M; Hernández-Afonso J; Rodríguez-Esteban M; de León-Hernández JC; Grillo-Pérez JJ
    Rev Esp Cardiol (Engl Ed); 2013 Mar; 66(3):193-7. PubMed ID: 24775453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of arrhythmias in myotonic dystrophy: trial design of the RAMYD study.
    Dello Russo A; Mangiola F; Della Bella P; Nigro G; Melacini P; Bongiorni MG; Tondo C; Calò L; Messano L; Pace M; Pelargonio G; Casella M; Sanna T; Silvestri G; Modoni A; Zachara E; Moltrasio M; Morandi L; Nigro G; Politano L; Palladino A; Bellocci F
    J Cardiovasc Med (Hagerstown); 2009 Jan; 10(1):51-8. PubMed ID: 19708226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term follow-up of arrhythmias in patients with myotonic dystrophy treated by pacing: a multicenter diagnostic pacemaker study.
    Lazarus A; Varin J; Babuty D; Anselme F; Coste J; Duboc D
    J Am Coll Cardiol; 2002 Nov; 40(9):1645-52. PubMed ID: 12427418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term arrhythmia follow-up of patients with myotonic dystrophy.
    Benhayon D; Lugo R; Patel R; Carballeira L; Elman L; Cooper JM
    J Cardiovasc Electrophysiol; 2015 Mar; 26(3):305-10. PubMed ID: 25546341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mortality in myotonic dystrophy patients in the area of prophylactic pacing devices.
    Laurent V; Pellieux S; Corcia P; Magro P; Pierre B; Fauchier L; Raynaud M; Babuty D
    Int J Cardiol; 2011 Jul; 150(1):54-8. PubMed ID: 20227121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Myotonic dystrophy and heart disease: behavior of arrhythmic events and conduction disturbances].
    Nishioka SA; Martinelli Filho M; Marie S; Zatz M; Costa R
    Arq Bras Cardiol; 2005 Apr; 84(4):330-6. PubMed ID: 15880208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.